[Type 2N von Willebrand disease (Normandy)].

Area of Science:

• Hematology
• Molecular Biology
• Genetics

Background:

• Von Willebrand disease (VWD) is the most prevalent inherited bleeding disorder, stemming from defects in von Willebrand factor (vWF).
• VWD manifests with mucosal bleeding and variable clinical severity.
• Type 2N VWD, also known as Normandy, is a rare subtype characterized by a qualitative vWF defect.

Observation:

• Type 2N VWD specifically impairs the vWF's capacity to bind with factor VIII.
• This interaction defect results in prolonged activated partial thromboplastin time (APTT).
• Affected individuals exhibit reduced factor VIII levels and normal or low vWF levels.

Findings:

• The laboratory findings in Type 2N VWD can be mistaken for mild hemophilia A.
• This diagnostic challenge arises from the combined APTT prolongation, low factor VIII, and normal/subnormal vWF.
• Accurate differentiation is crucial for appropriate patient management.

Implications:

• Misdiagnosis of Type 2N VWD as hemophilia A can lead to incorrect treatment strategies.
• Understanding the distinct pathophysiology of Type 2N VWD is essential for targeted therapeutic approaches.
• Improved diagnostic criteria and awareness can prevent treatment errors and optimize patient outcomes.